He S et al. |
Identification, organ expression and ligand-dependent expression levels of peroxisome proliferator activated receptors in grass carp (Ctenopharyngodon idella). |
2012 |
Comp. Biochem. Physiol. C Toxicol. Pharmacol. |
pmid:22079418
|
Collin M et al. |
Role of peroxisome proliferator-activated receptor-gamma in the protection afforded by 15-deoxydelta12,14 prostaglandin J2 against the multiple organ failure caused by endotoxin. |
2004 |
Crit. Care Med. |
pmid:15090969
|
Cuzzocrea S |
Peroxisome proliferator-activated receptors and acute lung injury. |
2006 |
Curr Opin Pharmacol |
pmid:16580256
|
Yasugi E et al. |
Peroxisome proliferator-activated receptor gamma ligands stimulate myeloid differentiation and lipogenensis in human leukemia NB4 cells. |
2006 |
Dev. Growth Differ. |
pmid:16573735
|
Souza SC et al. |
BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones. |
1998 |
Diabetes |
pmid:9568706
|
Maggi LB et al. |
Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression. |
2000 |
Diabetes |
pmid:10868955
|
Xie Y et al. |
Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins. |
2006 |
Diabetes Obes Metab |
pmid:16367886
|
Artwohl M et al. |
Thiazolidinediones inhibit proliferation of microvascular and macrovascular cells by a PPARgamma-independent mechanism. |
2005 |
Diabetologia |
pmid:15729575
|
Bruck R et al. |
Additive inhibitory effect of experimentally induced hepatic cirrhosis by agonists of peroxisome proliferator activator receptor gamma and retinoic acid receptor. |
2009 |
Dig. Dis. Sci. |
pmid:18594976
|
Kim WJ et al. |
Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A. |
2007 |
EMBO J. |
pmid:18034160
|
Suzuki T et al. |
Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions. |
2006 |
Endocr. Relat. Cancer |
pmid:16601291
|
Schell C et al. |
15-Deoxy-delta 12-14-prostaglandin-J2 induces hypertrophy and loss of contractility in human testicular peritubular cells: implications for human male fertility. |
2010 |
Endocrinology |
pmid:20133451
|
Tomlinson JW et al. |
Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. |
2001 |
Endocrinology |
pmid:11316764
|
Poncin S et al. |
Oxidative stress in the thyroid gland: from harmlessness to hazard depending on the iodine content. |
2008 |
Endocrinology |
pmid:17884933
|
Pirianov G et al. |
The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J(2) delays lipopolysaccharide-induced preterm delivery and reduces mortality in the newborn mouse. |
2009 |
Endocrinology |
pmid:18845626
|
Ding Q et al. |
Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes. |
2009 |
Endocrinology |
pmid:19074584
|
GarcÃa-Bueno B et al. |
Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-gamma activation after stress in rats. |
2008 |
Endocrinology |
pmid:18079203
|
Person EC et al. |
Albumin regulates induction of peroxisome proliferator-activated receptor-gamma (PPARgamma) by 15-deoxy-delta(12-14)-prostaglandin J(2) in vitro and may be an important regulator of PPARgamma function in vivo. |
2001 |
Endocrinology |
pmid:11159824
|
Landrier JF et al. |
Adiponectin expression is induced by vitamin E via a peroxisome proliferator-activated receptor gamma-dependent mechanism. |
2009 |
Endocrinology |
pmid:19833717
|
Lecka-Czernik B et al. |
Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. |
2002 |
Endocrinology |
pmid:12021203
|
Fang M et al. |
Activation of Human Peroxisome Proliferator-Activated Nuclear Receptors (PPARγ1) by Semi-Volatile Compounds (SVOCs) and Chemical Mixtures in Indoor Dust. |
2015 |
Environ. Sci. Technol. |
pmid:26172262
|
Quinteiro MS et al. |
The indirect antinociceptive mechanism of 15d-PGJ2 on rheumatoid arthritis-induced TMJ inflammatory pain in rats. |
2012 |
Eur J Pain |
pmid:22354681
|
Dubourdeau M et al. |
Opposite roles of STAT and PPARgamma in the induction of p21WAF1 expression by IL-13 in human peripheral blood monocytes. |
2008 |
Eur. Cytokine Netw. |
pmid:19103521
|
Liu X et al. |
15-Deoxy-Δ(12,14)-prostaglandin J(2) attenuates the biological activities of monocyte/macrophage cell lines. |
2012 |
Eur. J. Cell Biol. |
pmid:22560326
|
Pustovrh MC et al. |
MMP/ TIMP balance is modulated in vitro by 15dPGJ(2) in fetuses and placentas from diabetic rats. |
2009 |
Eur. J. Clin. Invest. |
pmid:19811527
|
Harris SG and Phipps RP |
The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis. |
2001 |
Eur. J. Immunol. |
pmid:11298334
|
Berry A et al. |
IL-13 induces expression of CD36 in human monocytes through PPARgamma activation. |
2007 |
Eur. J. Immunol. |
pmid:17458857
|
Faveeuw C et al. |
Prostaglandin D2 inhibits the production of interleukin-12 in murine dendritic cells through multiple signaling pathways. |
2003 |
Eur. J. Immunol. |
pmid:12672054
|
Comabella M et al. |
Plasma levels of 15d-PGJ are not altered in multiple sclerosis. |
2009 |
Eur. J. Neurol. |
pmid:19538219
|
Bernardo A et al. |
Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions. |
2000 |
Eur. J. Neurosci. |
pmid:10947800
|
Aoun P et al. |
Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells. |
2003 |
Eur. J. Pharmacol. |
pmid:12860474
|
Sugimoto H et al. |
CRTH2-specific binding characteristics of [3H]ramatroban and its effects on PGD2-, 15-deoxy-Delta12, 14-PGJ2- and indomethacin-induced agonist responses. |
2005 |
Eur. J. Pharmacol. |
pmid:16256979
|
Tang FT et al. |
Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression. |
2011 |
Eur. J. Pharmacol. |
pmid:20854809
|
Tanaka T et al. |
Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration. |
2005 |
Eur. J. Pharmacol. |
pmid:15680279
|
Ou YC et al. |
Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT. |
2007 |
Eur. J. Pharmacol. |
pmid:17341418
|
Inoue K et al. |
Effect of 15-deoxy-delta 12,14-prostaglandin J2 on acute lung injury induced by lipopolysaccharide in mice. |
2003 |
Eur. J. Pharmacol. |
pmid:14642794
|
Collin M and Thiemermann C |
The PPAR-gamma ligand 15-deoxy(delta12,14) prostaglandin J2 reduces the liver injury in endotoxic shock. |
2003 |
Eur. J. Pharmacol. |
pmid:12969773
|
Ferreira-Silva V et al. |
Effects of 15-deoxy-Delta12, 14 prostaglandin J2 and ciglitazone on human cancer cell cycle progression and death: the role of PPARgamma. |
2008 |
Eur. J. Pharmacol. |
pmid:18054911
|
Belvisi MG et al. |
Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation. |
2006 |
Eur. J. Pharmacol. |
pmid:16458290
|
Kitamura Y et al. |
Effects of 15-deoxy-delta(12,14) prostaglandin J(2) and interleukin-4 in Toll-like receptor-4-mutant glial cells. |
2001 |
Eur. J. Pharmacol. |
pmid:11164379
|
Neri T et al. |
Role of NF-kappaB and PPAR-gamma in lung inflammation induced by monocyte-derived microparticles. |
2011 |
Eur. Respir. J. |
pmid:21148223
|
Genovese T et al. |
Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury. |
2005 |
Eur. Respir. J. |
pmid:15684285
|
Tsao WC et al. |
Proteasome inhibitors induce peroxisome proliferator-activated receptor transactivation through RXR accumulation and a protein kinase C-dependent pathway. |
2005 |
Exp. Cell Res. |
pmid:15707588
|
Syed MA et al. |
Expression of TREM-1 is inhibited by PGD2 and PGJ2 in macrophages. |
2010 |
Exp. Cell Res. |
pmid:20797396
|
Hossain MS et al. |
Stable expression of lipocalin-type prostaglandin D synthase in cultured preadipocytes impairs adipogenesis program independently of endogenous prostanoids. |
2012 |
Exp. Cell Res. |
pmid:22100987
|
Rajasingh J and Bright JJ |
15-Deoxy-delta12,14-prostaglandin J2 regulates leukemia inhibitory factor signaling through JAK-STAT pathway in mouse embryonic stem cells. |
2006 |
Exp. Cell Res. |
pmid:16737695
|
Huang WC et al. |
Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929. |
2002 |
Exp. Cell Res. |
pmid:12083801
|
Park KS et al. |
Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway. |
2004 |
Exp. Cell Res. |
pmid:15212945
|
Kondoh K et al. |
Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells. |
2007 |
Exp. Cell Res. |
pmid:17706193
|
Richard CL et al. |
15-Deoxy-delta(12,14)-prostaglandin J(2) down-regulates CXCR4 on carcinoma cells through PPARgamma- and NFkappaB-mediated pathways. |
2007 |
Exp. Cell Res. |
pmid:17707368
|